Livagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed for liver and immune system restoration, studied for hepatoprotective properties and immune cell normalization in animal models of aging and hepatotoxicity.
Russian Bioregulator Peptide
Livagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed for liver and immune system restoration, studied for hepatoprotective properties and immune cell normalization in animal models of aging and hepatotoxicity.
Research Use Only — not intended for human consumption
Research peptides are sold for laboratory use only and are not intended for human consumption.
Week-by-week dosing, reconstitution steps, supplies checklist, and cycle tips.
Week-by-week dosing protocolNo clinics in our directory yet. Browse all clinics.
Find a Peptide Clinic Near YouArticles about Livagen and related topics
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
Looking for where to buy retatrutide for research use? Here’s a supplier checklist (COAs, testing, reviews, red flags) plus the clinical-trial pathway for legitimate access.
The injectable peptides craze is sweeping the US, with many individuals experimenting for various health benefits. Learn the key facts and implications for patients.
MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.